A Japanese-American woman with advanced Alzheimer’s disease showed noticeable improvements after she took a high dose of magic mushrooms in a case study.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.
As someone educated in statistics, I have a pretty good idea about what you can learn from a sample size of one. It’s about as close to nothing as you can get without it quite being nothing.
Except pilots, people driving vehicles, surgeons, EMTs, and quite a lot of other people, not to mention those of us who have a rough time on psychedelics.
Nothing suits everyone, and even for those who benefit from it, there’s an appropriate time and place.
A close friend of mine, in his late 70s, was experiencing increasingly uniform, flat moods. This happens sometime to older people, due to neurotransmitter depletion. He microdosed on shrooms for a month and was back to his old, vibrant self for the better part of a year afterwards.
Another single-person study, but I give this anecdata a bit more weight because I know the guy well. If that’s a placebo effect, I still want some.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
Anyway, with that said, here’s a link to the case study since CTV’s seems to be malformatted.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.
As someone educated in statistics, I have a pretty good idea about what you can learn from a sample size of one. It’s about as close to nothing as you can get without it quite being nothing.
Everyone should be doing shrooms.
Except pilots, people driving vehicles, surgeons, EMTs, and quite a lot of other people, not to mention those of us who have a rough time on psychedelics.
Nothing suits everyone, and even for those who benefit from it, there’s an appropriate time and place.
Apply that to everything in the universe. 🙄
They should be accessible to everyone and destigmatized for sure.
Not everyone wants to do them though, and those people shouldn’t.
Except people with dormant or active mental illness.
Idk I’ve found shrooms to really help with my depression. Obviously with mental illness you should be careful about it more so than usual though
A close friend of mine, in his late 70s, was experiencing increasingly uniform, flat moods. This happens sometime to older people, due to neurotransmitter depletion. He microdosed on shrooms for a month and was back to his old, vibrant self for the better part of a year afterwards.
Another single-person study, but I give this anecdata a bit more weight because I know the guy well. If that’s a placebo effect, I still want some.